Sign inGet started

Rangwala Reshma

Insider CIK 1825322 · KPTI EVP & Chief Medical Officer · ARAV Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KPTI Karyopharm Therapeutics In S Sale2026-05-142026-05-15408$9.50 $3.9K56,829SEC↗
KPTI Karyopharm Therapeutics In A Award2026-05-132026-05-15947— $057,237SEC↗
KPTI Karyopharm Therapeutics In S Sale2026-04-212026-04-22449$8.94 $4.0K56,290SEC↗
KPTI Karyopharm Therapeutics In S Sale2026-03-022026-03-035,066$9.41 $47.7K56,739SEC↗
KPTI Karyopharm Therapeutics In A Award2026-01-312026-02-0332,415— $061,805SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-09-152025-09-16408$6.43 $2.6K29,390SEC↗
KPTI Karyopharm Therapeutics In A Award2025-09-122025-09-16945— $029,798SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-04-232025-04-24419$6.17 $2.6K28,853SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-03-042025-03-063,587$6.29 $22.6K29,272SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-0410,833— $010,833SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-049,166— $09,166SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-045,416— $028,276SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-044,583— $032,859SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-04-222024-04-236,789$1.17 $7.9K342,931SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-03-012024-03-045,969$1.20 $7.2K349,720SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-02-292024-03-0415,667$1.17 $18.3K355,689SEC↗
KPTI Karyopharm Therapeutics In A Award2024-02-282024-02-29198,959— $0371,356SEC↗
KPTI Karyopharm Therapeutics In A Award2024-01-242024-01-2514,167— $0172,397SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-04-202023-04-246,655$4.05 $27.0K158,230SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-04-202023-04-24115$4.03 $463164,885SEC↗
KPTI Karyopharm Therapeutics In A Award2023-02-282023-03-02100,000— $0165,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-04-292022-05-02100,000— $0100,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-04-292022-05-0265,000— $065,000SEC↗
ARAV Aravive, Inc. A Award deriv2022-01-242022-01-25175,000— $0175,000SEC↗
ARAV Aravive, Inc. A Award deriv2021-01-252021-01-2610,000— $010,000SEC↗
ARAV Aravive, Inc. A Award deriv2020-09-282020-09-2975,000— $075,000SEC↗